S&P 500   4,592.03 (+1.18%)
DOW   35,254.94 (+1.95%)
QQQ   384.40 (+0.33%)
AAPL   166.15 (+2.66%)
MSFT   323.00 (+0.00%)
FB   315.07 (+2.68%)
GOOGL   2,844.97 (+0.17%)
AMZN   3,436.15 (+1.37%)
TSLA   989.00 (-2.56%)
NVDA   293.28 (-4.45%)
BABA   120.52 (+7.65%)
NIO   32.10 (-0.16%)
CGC   9.93 (-0.60%)
AMD   135.96 (-5.59%)
GE   96.51 (+4.03%)
MU   82.09 (+0.58%)
T   23.48 (+0.09%)
F   19.26 (+0.63%)
DIS   149.97 (+2.56%)
PFE   52.02 (-4.15%)
AMC   28.61 (-1.38%)
ACB   5.89 (+1.20%)
BA   205.53 (+3.55%)
S&P 500   4,592.03 (+1.18%)
DOW   35,254.94 (+1.95%)
QQQ   384.40 (+0.33%)
AAPL   166.15 (+2.66%)
MSFT   323.00 (+0.00%)
FB   315.07 (+2.68%)
GOOGL   2,844.97 (+0.17%)
AMZN   3,436.15 (+1.37%)
TSLA   989.00 (-2.56%)
NVDA   293.28 (-4.45%)
BABA   120.52 (+7.65%)
NIO   32.10 (-0.16%)
CGC   9.93 (-0.60%)
AMD   135.96 (-5.59%)
GE   96.51 (+4.03%)
MU   82.09 (+0.58%)
T   23.48 (+0.09%)
F   19.26 (+0.63%)
DIS   149.97 (+2.56%)
PFE   52.02 (-4.15%)
AMC   28.61 (-1.38%)
ACB   5.89 (+1.20%)
BA   205.53 (+3.55%)
S&P 500   4,592.03 (+1.18%)
DOW   35,254.94 (+1.95%)
QQQ   384.40 (+0.33%)
AAPL   166.15 (+2.66%)
MSFT   323.00 (+0.00%)
FB   315.07 (+2.68%)
GOOGL   2,844.97 (+0.17%)
AMZN   3,436.15 (+1.37%)
TSLA   989.00 (-2.56%)
NVDA   293.28 (-4.45%)
BABA   120.52 (+7.65%)
NIO   32.10 (-0.16%)
CGC   9.93 (-0.60%)
AMD   135.96 (-5.59%)
GE   96.51 (+4.03%)
MU   82.09 (+0.58%)
T   23.48 (+0.09%)
F   19.26 (+0.63%)
DIS   149.97 (+2.56%)
PFE   52.02 (-4.15%)
AMC   28.61 (-1.38%)
ACB   5.89 (+1.20%)
BA   205.53 (+3.55%)
S&P 500   4,592.03 (+1.18%)
DOW   35,254.94 (+1.95%)
QQQ   384.40 (+0.33%)
AAPL   166.15 (+2.66%)
MSFT   323.00 (+0.00%)
FB   315.07 (+2.68%)
GOOGL   2,844.97 (+0.17%)
AMZN   3,436.15 (+1.37%)
TSLA   989.00 (-2.56%)
NVDA   293.28 (-4.45%)
BABA   120.52 (+7.65%)
NIO   32.10 (-0.16%)
CGC   9.93 (-0.60%)
AMD   135.96 (-5.59%)
GE   96.51 (+4.03%)
MU   82.09 (+0.58%)
T   23.48 (+0.09%)
F   19.26 (+0.63%)
DIS   149.97 (+2.56%)
PFE   52.02 (-4.15%)
AMC   28.61 (-1.38%)
ACB   5.89 (+1.20%)
BA   205.53 (+3.55%)
NASDAQ:QLGN

Qualigen Therapeutics SEC Filings & 10K Form

$1.08
-0.08 (-6.52%)
(As of 12/6/2021 12:15 PM ET)
Add
Compare
Today's Range
$1.03
$1.13
50-Day Range
$0.94
$2.56
52-Week Range
$0.93
$4.66
Volume
38,030 shs
Average Volume
20.98 million shs
Market Capitalization
$31.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.67

Qualigen Therapeutics (NASDAQ:QLGN) SEC Filings

DateFilerForm TypeView
08/20/2021
2:05 PM
Kruger Kurt H (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2021
3:05 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2021
5:14 AM
ARSHAD TARIQ (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
4:21 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2021
3:23 PM
ARSHAD TARIQ (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2021
12:01 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2021
2:16 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form DEF 14A
04/26/2021
5:16 PM
BROIDRICK AMY S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2021
2:18 PM
Poirier Michael S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2021
5:15 AM
Lotz Christopher L. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2021
3:10 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2021
8:15 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2020
5:05 AM
Kruger Kurt H (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
3:44 PM
BROIDRICK AMY S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
2:54 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
12:26 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 424B5
12/08/2020
11:31 AM
EMERY SIDNEY W JR (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
8:30 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
3:32 PM
EMERY SIDNEY W JR (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/23/2020
8:11 PM
Kruger Kurt H (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
4:14 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2020
3:15 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2020
3:15 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
3:53 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/28/2020
1:01 PM
BROIDRICK AMY S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
12:59 PM
BROIDRICK AMY S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2020
7:00 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
3:22 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2020
8:54 PM
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
SEKISUI DIAGNOSTICS, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
5:16 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 424B5
07/10/2020
3:40 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
1:35 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 424B5
07/09/2020
5:02 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
11:32 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
8:27 PM
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Ritter Ira E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:26 PM
David Richard A. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:26 PM
Poirier Michael S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:24 PM
Abdul-Ahad Wajdi (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:23 PM
Kruger Kurt H (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:23 PM
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Sinha Shishir K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:22 PM
Korenberg Matthew E (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:21 PM
Lotz Christopher L. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
2:48 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K/A
06/01/2020
3:46 PM
Greenblock Capital, LLC (Filed by)
Qualigen Therapeutics, Inc. (Subject)
Qualigen Therapeutics (Subject)
Form SC 13G
05/29/2020
4:17 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
4:03 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
6:12 PM
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
SEKISUI DIAGNOSTICS, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
5:07 PM
Abdul-Ahad Wajdi (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:05 PM
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Sinha Shishir K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:04 PM
Poirier Michael S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:03 PM
Lotz Christopher L. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:01 PM
Kruger Kurt H (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
4:59 PM
David Richard A. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
4:10 PM
Poirier Michael S. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:08 PM
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Sinha Shishir K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:07 PM
Korenberg Matthew E (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:05 PM
Lotz Christopher L. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:03 PM
Kruger Kurt H (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:01 PM
David Richard A. (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
2:25 PM
Abdul-Ahad Wajdi (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
11:57 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 424B5
05/20/2020
4:12 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form S-4MEF
05/19/2020
2:44 PM
Ritter Ira E. (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
2:43 PM
Beck John W (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
2:42 PM
Ritter Andrew J (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
4:12 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
4:10 PM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
05/14/2020
8:50 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 424B3
05/11/2020
7:03 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
7:02 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
05/06/2020
8:22 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
05/05/2020
5:13 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
05/01/2020
4:31 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2020
4:30 PM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
05/01/2020
4:29 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
6:35 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
04/21/2020
5:10 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
04/21/2020
5:06 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
04/09/2020
11:15 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form EFFECT
04/09/2020
8:30 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 424B3
04/06/2020
4:18 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form S-4/A
04/06/2020
5:15 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form S-4/A
03/31/2020
4:29 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
4:27 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2020
5:15 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form NT 10-K
03/27/2020
4:31 PM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form S-4/A
03/16/2020
4:53 PM
Doyle Noah (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:26 PM
Ritter Ira E. (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:13 PM
Ritter Andrew J (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
7:32 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
7:30 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
03/03/2020
5:17 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
5:15 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
03/03/2020
5:12 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 424B5
02/27/2020
8:00 PM
Doyle Noah (Reporting)
RITTER PHARMACEUTICALS INC (Issuer)
Qualigen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:52 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
6:50 AM
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form 425
02/14/2020
8:56 AM
Alyeska Investment Group, L.P. (Filed by)
RITTER PHARMACEUTICALS INC (Subject)
Qualigen Therapeutics (Subject)
Form SC 13G/A
02/04/2020
5:26 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
01/21/2020
8:20 AM
RITTER PHARMACEUTICALS INC (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.